NIAID | Technology Transfer

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Canada
2793128
Filed on 2000-09-22

HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES

Read more about HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES

US Application 13/675,447
Filed on 2012-11-13

Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof

Read more about Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof

Patent Cooperation Treaty
PCT/DK2010/050236
Filed on 2010-09-16

Negative Strand RNA Virus Replicon

Read more about Negative Strand RNA Virus Replicon

France
04776525.0
Filed on 2004-06-14

Negative Strand RNA Virus Replicon

Read more about Negative Strand RNA Virus Replicon

Switzerland
04776525.0
Filed on 2004-06-14

Negative Strand RNA Virus Replicon

Read more about Negative Strand RNA Virus Replicon

United Kingdom
04776525.0
Filed on 2004-06-14

Negative Strand RNA Virus Replicon

Read more about Negative Strand RNA Virus Replicon

Italy
04776525.0
Filed on 2004-06-14

Development Of Dengue Virus Vaccine Components

Read more about Development Of Dengue Virus Vaccine Components

European Patent
12182319.9
Filed on 2007-08-15

HIV Inhibitors

Read more about HIV Inhibitors

Patent Cooperation Treaty
PCT/US12/054009
Filed on 2012-09-06

NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES

Read more about NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES

Patent Cooperation Treaty
PCT/US2012/56822
Filed on 2012-09-24

Subscribe to NIAID